|
Deadline:
April 02, 2010
|
Français
|
 Instructions for Completing the On-Line Application FormIn order to ensure that your application is given the careful consideration that it deserves please be sure to complete all sections of the application form carefully. Only complete applications will be reviewed and will receive a response. The application form is divided into the following sections:
|
Welcome to the Pfizer Cardiovascular Grant on-line application process .
Pfizer Canada is strongly committed to improving cardiovascular health, and is pleased to support Canadian medical innovation through this research award program. This program aims to fund and support independent cardiovascular research in the areas of basic biomedical, clinical, health services and systems and health populations. An independent committee of Canadian medical researchers will review the research proposals and select award recipients. The committee will be chaired by
At Pfizer we are proud to support the innovators and ideas that make better health possible. Our mission is to support outstanding research with the potential to improve the cardiovascular health and quality of life of Canadians, and people around the world.
Pfizer is proud to announce the following awards and partnership awards for round 7 of the competition. Please click on the boxes below to find out more about eligible areas of research for each award.
Submissions will be entertained yearly and selected areas of research may vary from round to round. The deadline for the seventh round is April 2nd, 2010.
For the Ontario Lung Association/Pfizer Canada awards: deadline is December 4th 2009.
For the Kidney Foundation of Canada/Pfizer Canada - Cardio-Renal Research Award: deadline of the letter of intent: January 8th 2010.
Instructions for Completing the On-line Application Form
In order to ensure that your application is given the careful consideration that it deserves please be sure to complete all sections of the application form. Complete applications only will be reviewed and will receive a response. The application form is divided into the following sections:
- Attestation of Eligibility (confirmation that you meet the eligibility criteria)
- Applicant Information (contact information and professional experience)
- FCPA & Legal (government functions and legal information)
- Research Profile (classification of the type of research)
- Additional Funding Sources (if you are receiving funding from another source)
- Research Proposal Abstract (summary of research proposal)
- Budget Information (cost of conducting the proposed research)
- Research Proposal (in its entirety)
General Information
Applicable to all competitions within the Program
- Pfizer CV Research Awards :
- Diabetes and the metabolic syndrome: prevention, management, complications
- Thrombosis and hemostasis
- Heart failure (N.B.: Projects involving sildenafil will not be considered)
- Jean Davignon Distinguished Cardiovascular Metabolic Research Award :
- Stroke prevention and management
- Dyslipidemia, coronary artery disease & atherosclerosis
- Canadian Hypertension Society - Pfizer Award :
- Hypertension
- Kidney Foundation of Canada/Pfizer Canada - Cardio-Renal Research Award :
- Cardiovascular complications of chronic kidney disease
- Cardio-Respiratory Awards :
- National Smoking Cessation Award
- Ontario Lung Association/Pfizer Canada Awards :
- Ontario Lung Association/Pfizer Canada - Smoking Cessation Award
- Ontario Lung Association/Pfizer Canada - Pulmonary arterial hypertension award
In order to be eligible to apply for any award described hereunder, you must meet the following criteria:
- You are an M.D., Ph.D. or Pharm.D.
- You are a Canadian citizen or landed immigrant with permanent Canadian residence
- You are not receiving funding from other pharmaceutical industry for the research proposal that is being submitted
- You are not receiving additional funding from the CIHR or other peer-reviewed Canadian Funding agencies overlapping the scope of the research proposal that is being submitted.
- You are affiliated with a Canadian academic or medical institution (e.g. hospital, university) and plan to conduct the reseach for which you are requesting funds, in Canada.
This program is for original work only.
The following is a list of types of research that are supported by the Pfizer Cardiovascular Research Awards Program:
- Basic/Fundamental Research i.e. in vitro, animal models etc.
- Clinical Research involving humans
- Outcomes Research or Epidemiological studies (e.g., structured surveys, pharmacoeconomics, disease management initiatives)
- Any trial involving humans must be conducted with respect of the ICH guidelines and the Canadian regulations.
The following is a list of examples of types of research that are not eligible for the Pfizer Cardiovascular Research Awards Program. Such studies will be excluded from the competition:
- Morbidity and mortality studies
- Repeats of existing studies
- Studies involving the administration and aiming to support the efficacy of a competitor drug or the use of a generic (it is best to address these proposals to the competitor/generic drug companies)
- Studies involving the use of unapproved Pfizer products are not eligible for the awards program.
- Submissions will be entertained yearly and selected areas of research may vary from round to round
- The deadline for the seventh round is April 2nd, 2010. For the Ontario Lung Association/Pfizer Canada awards, the deadline is December 4th 2009. For the Kidney Foundation of Canada/Pfizer Canada - Cardio-Renal Research Award, the deadline of the letter of intent is January 8th 2010.
The research proposal must be no more than 10 pages* (not including references & appendices). Reviewers will not review beyond this limit. Use standard ¾ inch margins, with font size of 10 to 12. Include the following:
- Clear statement of purpose/aims
- Timeline, methodologies and available facilities/resources
- Summary of relevant past work that is applicable to the project
- Summary of potential challenges and plans for addressing those obstacles
- Expected findings and potential impact of these findings, i.e., how your project will impact the health and quality of life of people with metabolic and cardiovascular disease
- Sample size justification and proposed analysis of the data (a statistician should be able to verify calculations and choice of methods of analyses).
The following limits apply for appendices:
- No more than 2 pages for figures and/or tables
- No more than 2 manuscripts and/or published articles
- No more than 1 page for answers to the Review Committee’s comments (for resubmission only)
You will also be asked to provide the following
- An official signed letter from your institution
- Your CV as well as the CV of any co-investigator, using the Canadian Institutes of Health Research format available on www.commoncv.net
- Letters of collaboration from collaborator responsible to conduct key aspects of the experimental plan
- A detailed budget
The program allows for the same proposal to be resubmitted once. However, applicants MUST address all comments made by the Review Committee at the earlier round (limit of 1 page).
*IMPORTANT: For the Ontario Lung Association Awards, applications should not exceed 6 pages. For the Kidney Foundation of Canada/Pfizer Canada - Cardio-Renal Research Award, please follow the invited application process a described on the award page.